Bal Pharma Ltd

NSE: BALPHARMA · BSE: 524824 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹97.50
Market cap: ₹155.2 Cr
Revenue (annual): ₹311.7 Cr
Net profit (annual): ₹6.28 Cr
P/E (TTM): 21.5×Sector 47.4×
Promoter holding: 50.86%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 7 Other Announcement 6 Management Change 4 Financial Results 3 Capital Structure Change 3 Dividend 2 Board Meeting Date 2 Price Movement Clarification 1 Merger & Restructuring 1 Legal & Regulatory 1 Fund Raise 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

32 announcements with these filters

15 Apr 2026 16:19 IST NSE

Other Announcement

Bal Pharma Other Announcement

Bal Pharma Limited submitted a compliance certificate for the quarter ended March 31, 2026, confirming the maintenance of a Structured Digital Database (SDD). The company certified that the database is non-tamperable, captures UPSI events, and maintains audit trails. This routine filing indicates full compliance with SEBI Prohibition of Insider Trading Regulations.

Read the filing ↗

6 Apr 2026 12:41 IST BSE

Other Announcement

Bal Pharma Other Announcement

Bal Pharma Ltd has submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The company confirmed that share certificates received for dematerialization were processed and depository records updated within the prescribed 15-day limit.

Read the filing ↗